Universitaetsklinikum Tuebingen AöR

Hematology and Cell Therapy

Clinical research includes acute myeloid leukemia, myelodysplastic neoplasms, chronic lymphocytic leukemia, lymphoma, and acute lymphoblastic leukemia, with activity across relapsed, refractory, and post-transplant settings.

  • Allogeneic stem cell transplantation
  • B-cell malignancies
  • Minimal residual disease
  • Leukemia vaccination

Research also covers fusion-driven sarcomas, fibrolamellar hepatocellular carcinoma, and immunotherapy-based approaches in advanced blood cancers and solid tumors.

Neuro-oncology and Neurology

Trials address glioblastoma, leptomeningeal disease, Parkinson disease, and disorders of brain injury and impaired vigilance, including hypoxic-ischemic encephalopathy and unresponsive wakefulness syndrome.

  • Intrathecal immunotherapy
  • Dopaminergic symptom control
  • Neurorecovery
  • Consciousness impairment

Additional work includes treatment strategies for chronic depression and neurological complications associated with severe illness.

Ophthalmology and Inherited Retinal Disease

Research activity includes acute central retinal artery occlusion, retinopathy of prematurity, achromatopsia, and retinitis pigmentosa, spanning both acquired and genetic causes of vision loss.

  • Retinal ischemia
  • Gene therapy
  • Prematurity-related eye disease
  • Visual function recovery

The portfolio reflects interest in restoring or preserving retinal function in paediatric and adult populations.

Pediatric, Neonatal, and Respiratory Care

Trials focus on extremely preterm infants, prematurity complications, and neonatal outcomes after asphyxia, with attention to respiratory support and neurodevelopment.

  • Mechanical ventilation
  • Therapeutic hypothermia
  • Neurodevelopmental impairment
  • Retinopathy of prematurity

Research also includes prevention and management of neonatal complications in intensive care settings.

Oncology, Metabolic Disease, and Infectious Disease

Studies extend to prostate cancer, rectal cancer, melanoma, and prediabetes, alongside work in malaria, COVID-19, and Staphylococcus aureus colonization.

  • PSMA-targeted therapy
  • Radiochemotherapy
  • Glucose metabolism
  • Vaccine immunogenicity

These trials encompass both cancer-directed treatment and prevention-oriented research in infectious and metabolic conditions.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study of venetoclax, treosulfan and fludarabine before stem cell transplant in patients with acute myeloid leukemia and myelodysplastic syndrome

    Recruiting

    2 1 1 1
    Germany
  • Study of intestinal gel containing levodopa, carbidopa and entacapone to treat motor and behavioral symptoms in patients with Parkinson’s disease

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany
  • Study on the Effectiveness of Atovaquone and Proguanil for Malaria Prevention in Healthy Volunteers

    Recruiting

    2 1 1
    Germany
  • Study on MB-CART2219.1 for Adults and Children with Relapsed or Refractory B-cell Malignancies

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany
  • Study of DNAJB1-PRKACA Peptide Vaccine for Patients with Fibrolamellar Hepatocellular Carcinoma and Other Tumors with Oncogenic Driver Fusion

    Recruiting

    1 1 1
    Germany
  • Study on the Safety and Effectiveness of Tafasitamab for Children with Relapsed or Refractory Acute B Lineage Leukemia

    Recruiting

    1 1 1 1
    Investigated drugs:
    Germany